Berkshire Hathaway’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414M Sell
1,857,752
-2,049,323
-52% -$464M 0.14% 24
2026
Q1
$661M Sell
3,907,075
-2,500,674
-39% -$436M 0.25% 22
2025
Q4
$1.05B Hold
6,407,749
0.38% 23
2025
Q3
$868M Sell
6,407,749
-206,363
-3% -$29.2M 0.32% 27
2025
Q2
$857M Buy
6,614,112
+857,602
+15% +$100M 0.33% 25
2025
Q1
$693M Buy
+5,756,510
New +$742M 0.27% 25

Other funds holding NUE

Berkshire Hathaway's NUE Position: Q2 2026 in Review

Berkshire Hathaway reduced its Nucor (NUE) stake by 52% in Q2 2026, selling an estimated $464M and leaving 1,857,752 shares worth $414M. The position accounts for 0.14% of the portfolio, ranked #24.

Berkshire Hathaway first reported a position in NUE in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.05B in Q4 2025. 1,542 funds tracked by Wall St. Rank hold NUE as of Q2 2026.

  • Berkshire Hathaway held 1,857,752 shares of Nucor worth $414M as of Q2 2026.
  • Berkshire Hathaway sold 2,049,323 Nucor shares in Q2 2026, an estimated $464M.
  • Nucor made up 0.14% of Berkshire Hathaway's portfolio in Q2 2026, its #24 holding.
  • Berkshire Hathaway first reported a position in Nucor in Q1 2025 and has held it in 6 quarters since.
  • Berkshire Hathaway's Nucor position peaked at $1.05B in Q4 2025.
  • 1,542 funds tracked by Wall St. Rank held Nucor as of Q2 2026.

Based on Berkshire Hathaway's 13F filing for Q2 2026, filed 14 Aug 2026.